Navigation Links
Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
Date:7/16/2008

ed to the following statements: Raptor's ability to develop DR Cysteamine to improve bioavailability, reduce side effects and reduce dosage frequency; Raptor's ability to develop DR Cysteamine for the treatment of Cystinosis; Raptor's ability to develop an appropriate dosage form of DR Cysteamine for NASH patients; and Raptor's ability to formulate and manufacture DR Cysteamine in clinical quantities to support clinical trials. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause our actual results to be materially different from these forward-looking statements. Factors which may significantly change or prevent our forward looking statements from fruition include that we may be unsuccessful in developing any products or acquiring products; that our technology may not be validated as we progress further and our methods may not be accepted by the scientific community; that we are unable to retain or attract key employees whose knowledge is essential to the development of our products; that unforeseen scientific difficulties develop with our process; that our patents are not sufficient to protect essential aspects of our technology; that competitors may invent better technology; that our products may not work as well as hoped or worse, that our products may harm recipients; and that we may not be able to raise sufficient funds for development or working capital when we require it. As well, our products may never develop into useful products and even if they do, they may not be approved for sale to the public. We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date they were made. Certain of these risks, uncertainties, and other factors are described in greater detail in our filings from time to time with the Securities and Exchange Commission (the "SEC"), which we strongly urge you to read and consider, including our Registration Statem
'/>"/>
SOURCE Raptor Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
2. Raptor Pharmaceuticals Provides Update of Product Programs
3. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
4. Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections
5. MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine
6. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Carotid Endarterectomy (CEA) Trial
7. Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
10. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
11. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... 2015  Recognizing the unique position Massachusetts ... the most respected organizations in the New England medtech community, ... Industry Council (MassMEDIC), have partnered to celebrate the region,s ... Annual Massachusetts Medtech Week. This celebration will take place May ... Center in Boston . For more information ...
(Date:4/27/2015)... Mass. , April 27, 2015 ... a collaboration with Brainlab AG, a leading software-driven ... planning and surgical navigation. The collaboration provides patients ... Stimulation (DBS) therapy. DBS is intended to treat ... help reduce symptoms for movement disorders such as ...
(Date:4/27/2015)... , April 27, 2015  CryoLife, Inc. (NYSE: ... processing company focused on cardiac and vascular surgery, announced ... the United States Food and Drug Administration ("FDA") verifying ... in place following the warning letter it received from ... letter follows a re-inspection in March 2015 by the ...
Breaking Medicine Technology:First Annual Massachusetts Medtech Week Celebrated this May 2First Annual Massachusetts Medtech Week Celebrated this May 3Boston Scientific Announces Strategic Collaboration With Brainlab AG 2Boston Scientific Announces Strategic Collaboration With Brainlab AG 3Boston Scientific Announces Strategic Collaboration With Brainlab AG 4CryoLife Announces Resolution of FDA Warning Letter 2
... Corporation , today announced that the U.S. Patent and ... which brings their total portfolio to 20 and bolsters ... wireless location systems (RTLS) for hospitals. (Logo: ... cover Awarepoint,s most accurate mesh-based location algorithm to date, ...
... opening ceremony for the world,s largest stem cell medical center ... ( www.rnl.co.kr ), South Korea,s premier adult stem cell firm ... in Beijing, China. Beijing RNL Stem Cell Medical Center is ... Li Hailing, www.yandaco.com ). Beijing RNL Stem Cell Medical ...
Cached Medicine Technology:Awarepoint Advances Industry Leadership with New Patented Technology 2RNL Opens the World's Largest Stem Cell Medical Center in Beijing, China 2
(Date:4/27/2015)... Philadelphia, PA (PRWEB) April 27, 2015 Ticket ... presale tickets in Philadelphia for his upcoming concert on ... The Beatles, will thrill his countless North American fans again ... in conjunction with his "Out There" tour. He will ... will be able to listen to this legendary performer for ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Doctors on ... working on a lien basis for over twenty years. So ... find the best doctor in the Fresno area , ... Dilanchian, DC and his team of medical specialists. With ... a massage therapist, Dilanchian Chiropractic is now helping ...
(Date:4/27/2015)... 2015 Douglas Fitzpatrick not only ... feel secure, but also helps secure homes for animals. On ... will be manning a booth at the 2015 Fetch A ... E. 17th Ave., Columbus, Ohio. , “I am very ... feature hundreds of adoptable pets from more than forty different ...
(Date:4/27/2015)... On May 15, Mount Soma Ashram students (monks) ... raise awareness of the vision of Mount Soma; the ... Ironically, when many of these people moved to the ... were leaving the social and technological world behind. Ashram ... service to a higher cause, deep introspection, and renunciation ...
(Date:4/27/2015)... Attorney Dan Newlin, of the Law Offices of Dan ... that commitment to a whole new level with the introduction ... for existing and potential clients to contact the law firm. ... value to the firm’s services, #Dan covers Central Florida, South ... offices. , “I knew the pound sign (#) could be ...
Breaking Medicine News(10 mins):Health News:Paul McCartney Presale Tickets at Wells Fargo Center in Philadelphia: Ticket Down Slashes Paul McCartney Ticket Prices in Philadelphia at the Wells Fargo Center 2Health News:Eminent Doctor Joins Forces with Doctors on Liens in Fresno 2Health News:Farmers Insurance Agent Douglas Fitzpatrick Ensures Pets Find Homes 2Health News:Mount Soma Monks Do Social Media 2Health News:Dan Newlin Hashtags It With #Dan 2
... study says more than a decade needed to ... -- The number of board-certified emergency doctors in ... hospital emergency department staffing needs in the future, ... scientists suggested that alternative strategies for staffing emergency ...
... announced the expansion of its Sealy office. , ... Sealy, Texas (PRWEB) ... of its Sealy office. Located on Meyer Street the five-year old-practice has ... in many of the surrounding communities as well., , , , ,The ...
... SANTA ANA, Calif., Jan. 9 Grubb & Ellis,Healthcare ... a two-property medical office building portfolio in San Antonio ... The acquisition closed in,December 2008. , ... Antonio, Pecan Valley Medical,Office Building consists of approximately 60,000 ...
... Cells , , NEW YORK, Jan. 9 ... free of signs of juvenile myelomonocytic leukemia (JMML), a ... a transplant with cord blood from the National Cord Blood ... Milstein National Cord Blood Center.Juvenile myelomonocytic leukemia generally affects children ...
... found impairments were mild, but they could signal later ... with diabetes now have to worry about whether their ... that declines in mental function are accelerated among those ... published in the January issue of Neuropsychology , ...
... led by The University of Texas Health Science Center ... train investigators in a ground-breaking area of genetic study ... are trying to discover why some people with known ... The answer may have to do with the interplay ...
Cached Medicine News:Health News:Certified ER Docs in Short Supply to Meet Future Needs 2Health News:Austin County Eye Expands Sealy Eye Clinic Office 2Health News:Grubb & Ellis Healthcare REIT Acquires Mountain Plains Portfolio in Texas 2Health News:Grubb & Ellis Healthcare REIT Acquires Mountain Plains Portfolio in Texas 3Health News:Grubb & Ellis Healthcare REIT Acquires Mountain Plains Portfolio in Texas 4Health News:Seventeen Months After Cord Blood Transplant - Child is Free of Signs of Cancer 2Health News:Diabetes Linked to Cognitive Problems 2Health News:UT leads $2.5 million training program in pioneering area of genetic research 2Health News:UT leads $2.5 million training program in pioneering area of genetic research 3
Set of six replacement burrs for E0824 Storz corneal burr set. Dull finish. Most popular size or model....
Replacement burr for E0819A or E0819B Algerbrush rust ring remover. Dull finish....
0.5 mm replacement burr for Algerbrush rust ring remover (E0815 A). Burr can also be used with Algerbrush rust ring remover (E0815 B). Dull finish....
5.5 mm disk shape burr. Diamond coated tip. Use with E0824 B handle....
Medicine Products: